MATN
Mateon Therapeutics, Inc.
MATN
MATN
Delisted
MATN was delisted on the 7th of December, 2016.
1 hedge funds and large institutions have $19K invested in Mateon Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
Holders
1
Holding in Top 10
–
Calls
–
Puts
$31K
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$679K | |
| 2 | -$489K | |
| 3 | -$94K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$37K |
| 5 |
Goldman Sachs
New York
|
-$17K |